Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study
详细信息 查看全文
- 作者：Arlene E Garcia-Soto ; MDa ; Arlene_e_garcia@hotmail.com" class="auth_mail" title="E-mail the corresponding author ; James J Java ; PhDb ; james.j.java@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Wilberto Nieves Neira ; MDa ; nwilberto@hotmail.com" class="auth_mail" title="E-mail the corresponding author ; J Matthew Pearson ; MDa ; mpearson@med.miami.edu" class="auth_mail" title="E-mail the corresponding author ; David E. Cohn ; MDc ; David.Cohn@osumc.edu" class="auth_mail" title="E-mail the corresponding author ; Shashikant B Lele ; MDd ; Shashi.Lele@RoswellPark.org" class="auth_mail" title="E-mail the corresponding author ; Krishnansu S Tewari ; MDe ; ktewari@uci.edu" class="auth_mail" title="E-mail the corresponding author ; Joan L Walker ; MDf ; joan-walker@ouhsc.edu" class="auth_mail" title="E-mail the corresponding author ; Angeles Alvarez Secord ; MDg ; angeles.secord@duke.edu" class="auth_mail" title="E-mail the corresponding author ; Deborah K Armstrong ; MDh ; ARMSTDE@jhmi.ed" class="auth_mail" title="E-mail the corresponding author ; Larry J Copeland ; MDc ; larry.copeland@osumc.edu" class="auth_mail" title="E-mail the corresponding author
- 关键词：Time interval between surgery and IP chemo ; Ovarian cancer ; NRG Oncology
- 刊名：Gynecologic Oncology
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：143
- 期：3
- 页码：484-489
- 全文大小：311 K
文摘
- em" id="list_l0005">
- el">•
Time from surgery to IP chemotherapy initiation (TSIC) did not impact survival.
- el">•
Gross residual disease was significantly associated with shorter TSIC.
- el">•
Gross residual disease significantly associated with higher risk of progression.